NFE2L2 and Alzheimer disease: In AD, Nrf2 predominantly exhibits a cytoplasmic localization in hippocampal neurons affected by the pathology [32], whereas in Parkinson’s disease (PD), neurons in the substantia nigra show a pronounced nuclear localization of Nrf2, likely indicating a compensatory response to elevated oxidative stress [32,33].